Plasmablastic lymphoma of the larynx: Report of two cases

Journal of Laryngology and Otology

Volumn 127, Issue 1, 2013, Pages 96-99

  Stephenson, K ^a   Peer, S ^a   Govender, D ^b   Fagan, J J ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Human Immunodeficiency Virus; Larynx; Lymphoma, B Cell; Lymphoma, Non Hodgkin's; Plasmablastic Lymphoma

Indexed keywords

ANTIRETROVIRUS AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; TUBERCULOSTATIC AGENT; VINCRISTINE;

ADULT; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CASE REPORT; CLINICAL EVALUATION; DIAGNOSTIC TEST; DISEASE DURATION; DYSPHAGIA; ENDOSCOPY; EPIGLOTTIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LARYNGEAL BIOPSY; LARYNGEAL PLASMABLASTIC LYMPHOMA; LARYNX TUMOR; LUNG TUBERCULOSIS; MACROCYTIC ANEMIA; MALE; NASENDOSCOPY; NONHODGKIN LYMPHOMA; ODYNOPHAGIA; PATHOPHYSIOLOGY; PLASMABLASTIC LYMPHOMA; REVIEW; TRACHEOSTOMY; TUMOR LOCALIZATION; TUMOR VOLUME; UPPER RESPIRATORY TRACT OBSTRUCTION; VOICE CHANGE;

ADULT; BIOPSY; DIAGNOSIS, DIFFERENTIAL; ENDOSCOPY; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC; MALE; MIDDLE AGED; PHOTOMICROGRAPHY;

EID: 84872287808     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215112002149     Document Type: Review

References (13)

1. Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U et al. Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection. Blood 1997;89: 1413-20 (Pubitemid 27080006)
2. Castillo JJ, Reagan JL. Plasmablastic lymphoma: A systematic review. Scientific World Journal 2011;11: 687-96
3. Castillo J, Pantanowitz L, Dezube B. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematology 2008;83: 804-9
4. Castillo JJ,Winer ES, Stachurski D, Perez K, Jabbour M, Milani C et al. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma 2010;51: 2047-53
5. Carbone A. AIDS-related non-Hodgkin's lymphomas: from pathology and molecular pathogenesis to treatment. Hum Pathol 2002;33: 392-404 (Pubitemid 34627589)
6. Rafaniello Raviele P, Pruneri G, Maiorano E. Plasmablastic lymphoma: A review. Oral Diseases 2009;15: 38-45
7. Bohlius J, Schmidlin K, Costagliola D, Fätkenheuer G, May M, Caro-Murillo AM et al. Incidence and risk factors of HIVrelated non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: A European multicohort study. Antivir Ther 2009;14: 1065-74
8. Thirlwell C, Sarker D, Stebbing J, Bower M. Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy. Clin Lymphoma 2003;4: 86-92 (Pubitemid 37304425)
9. Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF. HIVassociated lymphomas and gamma-herpesviruses. Blood 2009; 113: 1213-24
10. Carbone A, Gloghini A. Plasmablastic lymphoma: one or more? Am J Hematol 2008;83: 763-4
11. Dong HY, Scadden DT, de Leval L, Tang Z, Isaacson PG, Harris NL. Plasmablastic lymphoma in HIV-positive patients: An aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol 2005;29: 1633-41
12. Castillo JJ,Winer ES, Stachurski D, Perez K, Jabbour M, Milani C et al. Prognostic factors in chemotherapy-treated patients with HIV-associated plasmablastic lymphoma. Oncologist 2010;15: 293-9
13. Guan B, Zhang X, Ma H, Zhou H, Zhou X. A meta-analysis of highly active anti-retroviral therapy for treatment of plasmablastic lymphoma. Ann Saudi Med 2010;30: 123-8